Human adipose tissue-derived mesenchymal cells are easily available and autologous in origin, which may provide a source of adipose stem cells-derived insulin producing cells for cell replacement therapy in type 1 diabetes in the future. Here, INS is linked to type 1 diabetes mellitus.